Scarica l'app Stockscreener
0.646
2.05%
-0.0135
Precedente Chiudi:
$0.6595
Aprire:
$0.6511
Volume 24 ore:
128.46K
Relative Volume:
0.18
Capitalizzazione di mercato:
$4.72M
Reddito:
$29.78M
Utile/perdita netta:
$-39.94M
Rapporto P/E:
-0.0104
EPS:
-61.9139
Flusso di cassa netto:
$-16.12M
1 W Prestazione:
-12.82%
1M Prestazione:
-43.83%
6M Prestazione:
-90.25%
1 anno Prestazione:
-99.34%
Intervallo 1D:
$0.635
$0.6607
Intervallo di 1 settimana:
$0.635
$0.745
Portata 52W:
$0.635
$140.40
22nd Century Group, Inc. Stock (XXII) Company Profile
Nome
22nd Century Group, Inc.
Settore
Industria
Telefono
716-270-1523
Indirizzo
8560 Main Street, Williamsville, NY
Confronta XXII con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XXII
22nd Century Group, Inc.
|
0.646 | 4.72M | 29.78M | -39.94M | -16.12M | -61.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-07-21 | Iniziato | Alliance Global Partners | Buy |
| 2022-06-15 | Iniziato | Craig Hallum | Buy |
| 2022-03-08 | Iniziato | ROTH Capital | Buy |
| 2021-07-23 | Iniziato | Cowen | Outperform |
| 2017-10-16 | Reiterato | Chardan Capital Markets | Buy |
| 2016-08-11 | Reiterato | Chardan Capital Markets | Buy |
Mostra tutto
22nd Century Group, Inc. Borsa (XXII) Ultime notizie
22nd Century Group (Nasdaq: XXII) Appoints Accomplished Media Executive Lucille S. Salhany to Its Board - marketscreener.com
22nd Century Group, Inc. (NASDAQ:XXII) Sees Significant Drop in Short Interest - Defense World
22nd Century limits fiscal 2024 executive compensation, proposes another reverse stock split - Winston-Salem Journal
22nd Century Group (NASDAQ:XXII) Given Sell (E+) Rating at Weiss Ratings - Defense World
22nd Century Group (NASDAQ:XXII) Cut to “Sell” at Wall Street Zen - Defense World
22nd Century Modifies Securities Purchase Agreement - TipRanks
Emerging Growth Research Releases Q1 2025 Update Report on 22nd Century Group - The Globe and Mail
22nd Century to Present at the Emerging Growth Conference on May 21, 2025 | XXII Stock News - GuruFocus
12 Cannabis Stocks to Buy Now in 2025 - MarketBeat
22nd Century to Present at the Emerging Growth Conference on May 21, 2025 - The Manila Times
22nd Century Group, Inc. CEO Larry Firestone to Present Corporate Update at Emerging Growth Conference on May 21, 2025 - Nasdaq
22Nd Century Revenue Growth From Continued Expansion Of Cmo Volume - marketscreener.com
22nd Century Group, Inc. (NASDAQ:XXII) Q1 2025 Earnings Call Transcript - Insider Monkey
22nd Century Sees 50% Jump from Q4 2024 to Q1 2025 - Tobacco Reporter
22nd Century: Q1 Earnings Snapshot - CT Insider
22nd Century Group Inc (XXII) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
22nd Century Group Inc (XXII) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Restructuring - GuruFocus
22nd Century Group reports Q1 2025 earnings By Investing.com - Investing.com Nigeria
Earnings call transcript: 22nd Century Group Reports Q1 2025 Revenue Surge - Investing.com Australia
22nd Century Group Reports First Quarter 2025 Financial Results - GuruFocus
22ND CENTURY GROUP Earnings Results: $XXII Reports Quarterly Earnings - Nasdaq
22nd Century Group reports Q1 2025 earnings - Investing.com
22nd Century Group Reports 50% Sequential Sales Increase in First Quarter 2025, Advances Growth Strategy and New Product Launches - Nasdaq
22nd Century Group, Inc. (XXII): Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action and Deadline March 22, 2019 - ACCESS Newswire
Weiss Ratings Reiterates Sell (E) Rating for 22nd Century Group (NASDAQ:XXII) - Defense World
22nd Century files to sell 7.09M shares of common stock for holders - MSN
22nd Century Group Completes Sale of Needle Rock Farms Assets - The Manila Times
22nd Century Group Completes Sale of Needle Rock Farms Assets | XXII Stock News - GuruFocus
22nd Century Group, Inc. Enhances Balance Sheet with $770,000 Asset Sale Proceeds - Nasdaq
22nd Century Group reduces debt by $3.8 million - Investing.com Canada
22nd Century Group reduces debt by $3.8 million By Investing.com - Investing.com South Africa
Tag: Larry Firestone - Tobacco Reporter
22nd Century Further Reduces Debt by $1M - Tobacco Reporter
22nd Century Group (XXII) Reduces Debt by Another $1 Million | X - GuruFocus
22nd Century Group Further Reduces Debt By $1.0 Million Following Financing Transaction - marketscreener.com
22nd Century Group, Inc. Reports $1 Million Debt Repayment, Achieving $3.8 Million Year-to-Date Reduction - Nasdaq
22nd Century Group Further Reduces Debt by $1.0 Million Following Financing Transaction - The Manila Times
22nd Century Announces Q1 Webcast - Tobacco Reporter
22nd Century Group to Announce First Quarter 2025 Results on May 13, 2025 - The Manila Times
Anti-Nicotine Pioneer 22nd Century Group Sets Q1 2025 Earnings Date: Key Updates Coming May 13 - Stock Titan
22nd Century Group, Inc. Azioni (XXII) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.91%
1.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):